rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2007-7-4
|
pubmed:abstractText |
The conventional replacement therapy in Addison's disease (AD) does not restore the normal diurnal cortisol rhythm. We explored the feasibility and safety of continuous s.c. hydrocortisone infusion (CSHI) as a novel mode of glucocorticoid replacement therapy.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0804-4643
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
157
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
109-12
|
pubmed:dateRevised |
2009-6-8
|
pubmed:meshHeading |
pubmed-meshheading:17609409-Addison Disease,
pubmed-meshheading:17609409-Administration, Cutaneous,
pubmed-meshheading:17609409-Adult,
pubmed-meshheading:17609409-Circadian Rhythm,
pubmed-meshheading:17609409-Feasibility Studies,
pubmed-meshheading:17609409-Female,
pubmed-meshheading:17609409-Humans,
pubmed-meshheading:17609409-Hydrocortisone,
pubmed-meshheading:17609409-Infusion Pumps,
pubmed-meshheading:17609409-Male,
pubmed-meshheading:17609409-Middle Aged,
pubmed-meshheading:17609409-Saliva
|
pubmed:year |
2007
|
pubmed:articleTitle |
Continuous subcutaneous hydrocortisone infusion in Addison's disease.
|
pubmed:affiliation |
Division of Endocrinology, Institute of Medicine, University of Bergen, Norway. kristian.lovas@med.uib.no
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|